Kiefer F - Search Results

1

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.

Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Rüegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, Frank J, Nöthen MM, Rietschel M, Kiefer F, Mann KF, Weinshilboum RM, Frye MA, Choi DS. Karpyak VM, et al. Among authors: kiefer f. Transl Psychiatry. 2014 Oct 7;4(10):e462. doi: 10.1038/tp.2014.103. Transl Psychiatry. 2014. PMID: 25290263 Free PMC article.

2

[Psychosocial treatment plus drug prophylaxis. Fewer recurrences after alcohol withdrawal].

Smolka MN, Kiefer F, Mann K. Smolka MN, et al. Among authors: kiefer f. MMW Fortschr Med. 2003 Sep 4;145(35-36):45. MMW Fortschr Med. 2003. PMID: 14584210 German. No abstract available.

3

Combined therapy: what does acamprosate and naltrexone combination tell us?

Kiefer F, Wiedemann K. Kiefer F, et al. Alcohol Alcohol. 2004 Nov-Dec;39(6):542-7. doi: 10.1093/alcalc/agh093. Epub 2004 Sep 29. Alcohol Alcohol. 2004. PMID: 15456690

4

[Advances in the treatment of alcohol dependence: pharmacological relapse prevention].

Smolka MN, Kiefer F, Mann K. Smolka MN, et al. Among authors: kiefer f. MMW Fortschr Med. 2003 Oct 9;145 Suppl 3:65-9. MMW Fortschr Med. 2003. PMID: 15490769 Review. German.

5

Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.

Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, Wiedemann K. Kiefer F, et al. Eur Addict Res. 2005;11(2):83-91. doi: 10.1159/000083037. Eur Addict Res. 2005. PMID: 15785069 Clinical Trial.

6

Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.

Kiefer F, Jahn H, Otte C, Demiralay C, Wolf K, Wiedemann K. Kiefer F, et al. J Psychiatr Res. 2005 Sep;39(5):545-51. doi: 10.1016/j.jpsychires.2004.11.005. Epub 2005 Jan 21. J Psychiatr Res. 2005. PMID: 15992564 Clinical Trial.

7

New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.

Kiefer F, Mann K. Kiefer F, et al. Eur J Pharmacol. 2005 Dec 5;526(1-3):163-71. doi: 10.1016/j.ejphar.2005.09.028. Epub 2005 Nov 2. Eur J Pharmacol. 2005. PMID: 16266700 Review.

8

Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?

Kiefer F, Jahn H, Otte C, Naber D, Wiedemann K. Kiefer F, et al. Biol Psychiatry. 2006 Jul 1;60(1):74-6. doi: 10.1016/j.biopsych.2005.11.023. Epub 2006 Feb 14. Biol Psychiatry. 2006. PMID: 16483549 Clinical Trial.

9

Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.

Kiefer F, Jahn H, Otte C, Nakovics H, Wiedemann K. Kiefer F, et al. Neurosci Lett. 2006 Aug 14;404(1-2):103-6. doi: 10.1016/j.neulet.2006.05.015. Epub 2006 Jun 19. Neurosci Lett. 2006. PMID: 16782270

10

Pharmacotherapy and behavioral intervention for alcohol dependence.

Kiefer F, Mann K. Kiefer F, et al. JAMA. 2006 Oct 11;296(14):1727-8; author reply 1728-9. doi: 10.1001/jama.296.14.1727-b. JAMA. 2006. PMID: 17032980 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page